15 Unheard Ways To Achieve Greater Xarelto Lawsuit
Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical firms, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to perform so may be grounds for compensation. Our lawyers are working tough to get those hurt by the drug the compensation they are entitled to.
While bleeding can be a common complication associated with anticoagulants, it has been alleged that Xarelto is more harmful than standard blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, within the occasion of an emergency, sufferers may be at danger for irreversible bleeding issues, such as life-threatening internal and gastrointestinal hemorrhaging.
In the event you or perhaps a loved one particular suffered a serious bleeding event following taking xarelto how to say, you may have legal recourse. For a lot more information, get in touch with us right now to have your case reviewed, free of charge of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in cases of death, funeral costs. In addition, they are in search of punitive damages, which are usually awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for much more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.